Hydrix joins Ventri Clinical network

Announcement Hydrix joins Ventri Clinical network

Hydrix is pleased to announce it has joined the Ventri Clinical network, Australia’s Gateway for Cardiovascular Medtech Innovation.

Facilitated by the Australian Cardiovascular Alliance (ACvA) and supported by MTPConnect, the Charles Perkins Centre at Sydney University and the Victor Chang Cardiac Research Institute, the Ventri Clinical network was recently established to connect and empower businesses, clinicians and professionals who conduct, contribute to, or support the successful testing and study of Cardiovascular medical device innovations.

“Hydrix is one several additions to the Ventri Clinical fold since our recent inception and represents a company with a unique benefit and a clear vision”, said Anthony Murray, Ventri Clinical Director.  “Hydrix’s technical capabilities, CVD product insights, and strategic know-how, will benefit both patients and, we hope, the development of new technologies that result in improved heart health.”

Hydrix’s offers deep experience in cardiovascular medical device development, regulatory guidance, and clinical strategy services for clients around the world. It’s skills and experience are an ideal fit for the network which aims to build, connect and advise Australian CVD industry.

“Hydrix is excited at becoming a member of the Ventri Clinical network”, said Peter Lewis, Executive Vice President, Corporate Development. “We hope our medical device design and commercialisation know-how will be a valued addition to the network in terms of assisting and guiding members to more effectively translate their research into commercially successful products, as well as navigating regulatory submissions both in Australia and internationally. We look forward to increasingly establishing Australia as a major player in the global cardiovascular devices market”.

In addition to medical device development, Hydrix is a distributor of cardiac devices in APAC markets, and recently launched a platform technology, LUDO, to better facilitate the development of Mechanical Circulatory Support (MCS) devices.

Next Button.half
Previous Button.half